Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials2008 · 709 citations
2. 2Automated Abdominal Segmentation of CT Scans for Body Composition Analysis Using Deep Learning2018 · 361 citations
3. 3Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma2021 · 1,149 citations
4. 4Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans2007 · 1,428 citations
5. 5Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma2022 · 88 citations